Precision Medicine

Eli Lilly Expands Cancer Treatment Pipeline with $2.5 Billion Scorpion Therapeutics Deal

Eli Lilly and Company, a global leader in pharmaceutical innovation, announced its intent to acquire Scorpion Therapeutics’ experimental cancer therapy,…

56 years ago

Healthcare’s AI Gold Rush: Where to Invest in a Revolution

Imagine a healthcare system that's efficient, effective, and accessible to all. That's the promise of Artificial Intelligence (AI), and venture…

56 years ago